The Sovereign States Drug Consortium (SSDC) is a collaborative group of state Medicaid programs focused on containing pharmacy costs in their programs.
The primary purpose of the SSDC is the Member States' Medicaid supplemental drug rebate program. In this the focus of the program is on negotiating and acquiring rebates from drug manufacturers, supplemental to federal Medicaid rebates, for drugs utilized in the states' Medicaid program. At the same time, each state retains the ability to individually manage its pharmacy benefit, customizing its own Preferred Drug List and Prior Approval programs.
The SSDC also provides a forum for Member States to cooperate in other areas of pharmacy benefit administration and management in Medicaid and other publicly funded pharmacy benefit programs. One such project is a diabetic supply rebate program.
For rebate calendar years 2011 through 2013, Goold Health Systems of Augusta, Maine is the SSDC’s rebate negotiator. Goold was the SSDC’s supplemental rebate negotiator for calendar years 2006 through 2010. For more information on Goold see http://www.ghsinc.com.
For more information about the SSDC's Medicaid supplemental drug rebate program and its activities see the following links: